[O-08] Oral Session 08 ［Japanese］「Neuromuscular junction disorders 1」

[O-08-2] Interim Analyses of Efgartigimod PH20 SC in Participants With gMG in the ADAPT-SC+ Study

Masanori Takahashi¹, Howard Jr James F.², Li Yuebing³, Vu Tuan⁴, Korobko Denis⁵, Steeland Sophie⁶, Hoorick Benjamin Van⁶, Podhorna Jana⁶, Moana Hodari⁶, Kimiaki Utsugisawa⁷, Sacca Francesco⁸, Bleecker Jan L. De⁹, Mantegazza Renato¹⁰ (1.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 2.The University of North Carolina, USA, 3.Cleveland Clinic, USA, 4.Department of Neurology, University of South Florida Morsani College of Medicine, USA, 5.State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital", Russia, 6.argenx, Belgium, 7.Department of Neurology, Hanamaki General Hospital, Japan, 8.NRSO Department, Federico II University of Naples, Italy, 9.Ghent University Hospital, Belgium, 10.Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Italy)